New 3-substituted 1-(3-hydroxyphenyl)-5-oxopyrrolidine derivatives containing hydrazone, azole, diazole, oxadiazole fragments, as well as 2-phenoxy- and 2,3-diphenoxy-1,4-naphthoquinone derivatives were synthesized. The structure of all compounds has been confirmed by NMR, IR, mass spectra, and elemental analysis data. Methyl 1-{3-[(3-chloro-1,4-dioxo-1,4-dihydro-2-naphthalenyl)oxy]phenyl}-5-oxo-3-pyrrolidinecarboxylate demonstrated potential antibacterial and antifungal activities as determined by diffusion and serial dilution methods, while N'-[(4-bromophenyl)methylidene]-1-{3-[(3-chloro-1,4-dioxo-1,4-dihydro-2-naphthalenyl)oxy]phenyl}-5-oxo-3-pyrrolidinecarbohydrazide and 2-{3-[4-(1,2,3-oxadiazol-5-yl)-2-oxo-1-pyrrolidinyl]phenoxy}-3-{3-[4-(1,3,4-oxadiazol-2-yl)-2-oxo- 1-pyrrolidinyl]phenoxy}naphthoquinone showed antifungal activity against Candida tenuis and Aspergillus niger at low concentrations, as determined by the serial dilution method. The substitution of the methoxy fragment by N-containing substituents in monophenoxy substituted naphthoquinones was found to decrease their activity against Mycobacterium luteum. Besides, introduction of the second phenoxy substituted fragment increased the antifungal activity against Candida tenuis and Aspergillus niger at lower concentrations.
References
[1]
Zakharova, O.A.; Goryunov, L.I.; Troshkova, N.M.; Ovchinnikova, L.P.; Shteingarts, V.D.; Nevinsky, G.A. Cytotoxicity of new n-butylamino and sulfur-containing derivatives of polyfluorinated 1,4-naphthoquinone. Eur. J. Med. Chem. 2010, 45, 270–274, doi:10.1016/j.ejmech.2009.10.006.
[2]
Khalifa, M.M.A.; Ismail, M.M.F.; Noaman, E. synthesis and in vitro cytotoxic activity of novel benzo[b]phenazine-6,11-dione and 1,4-naphthoquinone derivatives. Bull. Pharmaceut. Sci. 2008, 31, 69–80.
Tandon, V.K.; Singh, R.V.; Yadav, D.B. Synthesis and Evaluation of Novel 1,4-Naphthoquinone Derivatives as Antiviral, Antifungal and Anticancer Agents. Bioorg. Med. Chem. Lett. 2004, 11, 2901–2904.
[5]
Oku, H.; Ishiguro, K. Cyclooxygenase-2 inhibitory 1,4-naphthoquinones from Impatiens balsamina L. Biol. Pharmaceut. Bull. 2002, 25, 658–660, doi:10.1248/bpb.25.658.
[6]
Checker, R.; Sharma, D.; Sandur, S.K.; Khanam, S.; Poduval, T.B. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes. Int. Immunopharm. 2009, 9, 949–958, doi:10.1016/j.intimp.2009.03.022.
[7]
Fry, M.; Pudney, M. Site of action of the antimalarial hydroxynaphthoquinone 2-[trans-4-(4′-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone. Biochem. Pharmacol. 1992, 43, 1545–1553, doi:10.1016/0006-2952(92)90213-3.
[8]
Ferreira, S.B.; da Silva, F.D.; Bezerra, F.A.F.M.; Lourenco, M.C.S.; Kaiser, C.R.; Pinto, A.C.; Ferreira, V.F. Synthesis of α- and β-Pyran Naphthoquinones as a New Classof Antitubercular Agents. Arch. Pharmazie. 2010, 343, 81–90.
[9]
Kim, H.W.; Lee, C.H.; Lee, H.S.J. Antibacterial activities of persimmon roots-derivedmaterials and 1,4-naphthoquinone's derivatives against intestinal bacteria. Food Sci. Biotechnol. 2009, 18, 755–760.
[10]
Santos, M.M.M.; Faria, N.; Iley, J.; Coles, S.J.; Hursthouse, M.B.; Martins, M.L.; Moreira, R. Reaction of Naphthoquinones with Substituted Nitromethanes. Facile Synthesis and Antifungal Activity of Naphtho[2,3-d]isoxazole-4,9-diones. Bioorg. Med. Chem. Lett. 2010, 20, 193–195, doi:10.1016/j.bmcl.2009.10.137. 19926280
[11]
Tandon, V.K.; Maurya, H.K.; Tripathi, A.; ShivaKeshava, G.B.; Shukla, P.K.; Srivastava, P.; Panda, D. 2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: Synthesis and biological evaluation as potential antiproliferative and antifungal agents. Eur. J. Med. Chem. 2009, 44, 1086–1092, doi:10.1016/j.ejmech.2008.06.025. 18708272
[12]
Griffiths, J. Benzoquinone and Naphthoquinone Dyes. In Ullmann‘s Encyclopedia of Industrial Chemistry; Elvers, B., Ed.; Wiley-VCH Verlag GmbH & Co. KgaA: Weinheim, Germany, 2006.
[13]
Hartmann, N.; Troll, T. Preparation of naphthoquinone imines as NIR dyes. Tetrahedron 1995, 51, 4655–4664, doi:10.1016/0040-4020(95)00163-3.
[14]
Matsui, M.; Taniguichi, S.; Suzuki, M.; Wang, M.; Funabiki, K.; Shiozaki, H. Dyes produced bythe reaction of 1,2,3,4-tetrafluoro-9,10-anthraquinones with bifunctional nucleophiles. Dyes Pigm. 2005, 65, 211–220, doi:10.1016/j.dyepig.2004.07.006.
[15]
Tandom, V.K.; Maurya, H.K.; Mishra, N.N.; Shukla, P.K. Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents. Eur. J. Med. Chem. 2009, 44, 3130–3137, doi:10.1016/j.ejmech.2009.03.006.
[16]
Aly, A.A.; Ishak, E.A.; Alsharari, M.A.; Al-Muaikel, N.S.; Bedaira, T.M.I. Aminonaphthoquinones in Heterocyclization. J. Heterocyclic Chem. 2012, 49, 9–20, doi:10.1002/jhet.639.
[17]
Brandelli, A.; Bizani, D.; Martinelli, M.; Stefani, V.; Gerbase, A.E. Antimicrobial activity of 1,4-naphthoquinones by metal complexation. Braz. J. Pharm. Sci. 2004, 40, 247–253.
[18]
Voskien？, A.; Sapijanskait？, B.; Mickevi？ius, V.; Kantminien？, K.; Stasevych, M.; Komarovska-Porokhnyavets, O.; Musyanovych, R.; Novikov, V. Synthesis, chemical properties, and antimicrobial activity of 2- and 2,3-substituted [(tetrahydro-2,4-dioxopyrimidin-1(2H)-yl)phenoxy]naphthalene-1,4-diones. Monatsh. Chem. 2011, 142, 529–537, doi:10.1007/s00706-011-0466-x.
[19]
Brokait？, K.; Mickevi？ius, V.; Mikulskien？, G. Synthesis and structural investigation of some 1,4-disubstituted 2-pyrrolidinones. Arkivoc 2006, ii, 61–67.
[20]
Mickevi？ius, V.; Vaickelionien？, R.; Jonu？kien？, I.; Mikulskien？, G.; Kantminien？, K. Synthesis and properties of 1-(3-(fluoromethyl and trifluoromethyl)phenyl)-5-oxopyrrolidine-3-carboxylic acid derivatives. Monatsh. Chem. 2009, 140, 1513–1522, doi:10.1007/s00706-009-0201-z.
[21]
Anusevi？ius, K.; Mickevi？ius, V.; Mikulskien？, G. Synthesis and structure of N-(4-bromophenyl)-N-carboxyethyl-beta-alanine derivatives. Chemija 2010, 21, 127–134.
[22]
National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Disk Susceptibility Tests, 4th ed.; NCCLS: Villanova, PA, USA, 1990. Approved Standards NCCLS Document M2-A4.
[23]
National Committee for Clinical Laboratory Standard (NCCLS). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium Forming Filamentous Fungi: Proposed Standard, Document M38-P; NCCLS: Wayne, PA, USA, 1998.
